Announced Thu, 14 May · 12:03 IST

Newspaper Publication for the Audited Financial Results for the Quarter and year ended 31.03.2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹6.20
prior close
₹5.96
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.0+3.2+3.2+0.8-3.2-4.8-5.6-7.3-7.3-9.7-14.4-4.8-8.1
Up moveDown movePending
AI summary

Arunjyoti Bio Ventures Ltd (Scrip Code: 530881) has published its audited financial results for Q4 and full year ended March 31, 2026. The results were approved by the Board of Directors on May 13, 2026 and published in newspapers (Financial Express and Nava Telangana) on May 14, 2026, in compliance with SEBI LODR regulations. The Board has recommended a final dividend of Rs. 2 per equity share (face value Rs. 2 each) for FY 2026, subject to shareholder approval. The auditors have issued an unmodified opinion on the financial statements. The results are available on BSE website and the company's website.

Likely market impact

The recommendation of dividend and clean audit opinion are positive signals for shareholders. The company has also disclosed the incremental impact of new labour codes (gratuity and compensated absences) in the financial statements, showing transparency in compliance with recent regulatory changes.